期刊文献+

单-ADP-核糖基转移酶3过表达对人乳腺癌细胞MDA-MB-231增殖、凋亡及侵袭的影响 被引量:2

Effects of overexpression of mono-ADP-ribosyltransferase 3 on proliferation,apoptosis and invasion of human breast cancer MDA-MB-231 cells
原文传递
导出
摘要 目的探讨单-ADP-核糖基转移酶3(mono-ADP-ribosyltransferase 3,ART3)过表达对人乳腺癌MDA-MB-231细胞增殖、凋亡及侵袭的影响。方法在Lipofectamine 2000的介导下,将ART3基因重组真核表达质粒pCMV-ART3-myc-tag转染人乳腺癌细胞MDA-MB-231,用G418进行稳定转染细胞株的筛选,同时设未转染组对照。Western blot法检测稳定转染细胞中ART3-myc-tag蛋白的表达,MTT法、流式细胞术和Transwell试验分别检测ART3对MDA-MB-231细胞增殖活力、凋亡及侵袭能力的影响。结果 ART3可在MDA-MB-231细胞中稳定过表达;ART3转染组细胞的增殖活力和侵袭能力均明显高于未转染组(P<0.05);ART3转染组细胞的凋亡率明显低于未转染组(P<0.05)。结论过表达ART3能促进乳腺癌细胞增殖、侵袭,并抑制其凋亡,本实验为进一步研究ART3基因在乳腺癌发生发展中的作用及其机制奠定了基础。 Objective To investigate the effects of overexpression of mono-ADP-ribosyltransferase 3 (ART3) on prolifera- tion, apoptosis and invasion of human breast cancer MDA-MB-231 cells. Methods MDA-MB-231 cells were transfected with recombinant plasmid pCMV-ART3-myc-tag in medication of Lipofectamine 2000, using those untransfected as control. The stable transfectants were screened with G418 and determined for expression of ART3 by Western blot, for proliferative activity by MTY assay, for invasion ability by Transwell assay and for apoptosis by flow cytometry. Results ART3 was stably overexpressed in MDA-MB-231 cells. Both the proliferation activity and invasion ability of MDA-MB-231 cells transfected with recombinant plasmid pCMV-ART3-myc-tag were significantly higher (P 〈 0. 05 ), while the apoptosis rate was significantly lower, than those untransfected (P 〈 0. 05 ). Conclusion The overexpression of ART3 promot- ed the proliferation and invasion while inhibited the apoptosis of breast cancer cells, which ladi a foundation of further study on role of ART3 in the tumorigenesis and development of breast cancer.
出处 《中国生物制品学杂志》 CAS CSCD 2014年第1期72-75,共4页 Chinese Journal of Biologicals
关键词 单-ADP-核糖基转移酶 乳腺癌 MDA—MB-23 1细胞 细胞增殖 细胞凋亡 侵袭 Mono-ADP-ribosyhransferase 3 (ART3) Breast cancer MDA-MB-231 cells Cell proliferation Cell apoptosis Invasion
  • 相关文献

参考文献14

  • 1Okazaki IJ, Moss J. Mono-ADP-ribosylation: a reversible post- translational modification of proteins [J]. Adv Pharmacol, 1996, 35 ( 1 ) : 247-280.
  • 2Corda D, Di Girolamo M. Functional aspects of protein mono- ADP-ribosylation [J]. EMBO J, 2003, 22 (9): 1953-1958.
  • 3Ludden PW. Reversible ADP-ribosylation as a mechanism of enzyme regulation in procaryotes [J]. Mol Cell Biochem, 1994, 138 (1-2): 123-129.
  • 4Braren R, Glowacki G, Nissen M, et al. Molecular characterization and expression of the gene for mouse NAD+: arginine ecto-mono (ADP-ribosyl) transferase Artl [J]. Biochem J, 1998, 336 (Pt 3): 561-568.
  • 5Chang P, Jacobson MK, Mitchison TJ. Poly (ADP-ribose) is required for spindle assembly and structure [J]. Nature, 2004, 432 (7017) : 645-649.
  • 6Chang W, Dynek JN, Smith S. NuMA is a major acceptor of poly (ADP-ribosyl) ation by tankyrase 1 in mitosis [J]. Biochem J, 2005, 391 (Pt 2): 177-184.
  • 7Goto S, Xue R, Sugo N, et al. Poly (ADP-ribose) polymerase impairs eal'ly and long-term experimental stroke recovery [J]. Stroke, 2002, 33 (4): 1101-1106.
  • 8Lodhi IJ, Cliff RE, Omann GM, et al. Inhibition of mono- ADP-ribosyhransferase activity during the execution phase of apoptosis prevents apoptotic body formation [J ]. Arch Biochem Biophys, 2001, 387 ( 1 ) : 66-77.
  • 9Okada H, Tajima A, Shichiri K, et al. Genome-wide expre- ssion of azoospermia testes demonstrates a specific profile and implicates ART3 in genetic susceptibility [J]. PloS Genet, 2008, 4 (2): e26.
  • 10Norambuena PA, Diblik J, Krenkova P, et al. An ADP-ribosy - ltransferase 3 (ART3) variant is associated with reduced sperm- counts in Czech males: case / control association study repli caring results from the Japanese population [J]. Neuro Endo- crinol Lett, 2012, 33 (1): 48-52.

同被引文献24

  • 1Maik Friedrich,Andreas Grahnert,Uwe Paasch,Andrea Tannapfel,Friedrich Koch-Nolte,Sunna Hauschildt.Expression of toxin-related human mono-ADP-ribosyltransferase 3 in human testes[J].Asian Journal of Andrology,2006,8(3):281-287. 被引量:6
  • 2HARBCCK N, SCHMITT M, KATCS R E. Clinical utility of urokinase-type plasminogen activator and plasrninogen activator inhibitor- 1 determination in primary breast cancer tissue for individualized therapy concepts (J 1. Clin Breast Cancer,2012,3(3) : 196.
  • 3JANICKC F, PRCCHTL A, THOMSSEN C. Randomized adjuvant chemotherapy trial in high risk, lymph node neg- ative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type l[J~. J Natl Cancer Inst,2011,93(12) :913.
  • 4VISVADER J E, LINDEMAN G J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions[ J]. Nat Rev Cancer,2008,8(10) :755.
  • 5DUFFY M J, MCGOWAN P M, HARBECK N, et al. uPA and PAI-1 as biomarkers in breast cancer: valida- ted for clinical use in level-of-evidence-1 studies [ J 1. Breast Cancer Research Bcr, 2014,16 (4) : 1.
  • 6BELLOCQ J P, LUPORSI E, BARRI~RE J,et al. uPA/ PAI-1, Oncotype DX, MammaPrint(?). Prognosis and predictive values for clinical utility in breast cancer man- agement~ J 1. Annales De Pathologie,2014,34 (5) :349.
  • 7AKUDUGU J, SERAFIN A, BHM L. Further evaluation of uPA and PAI-1 as biomarkers for prostatic diseases [ J 1. Journal of Cancer Research & Clinical Oncology, 2014,141(4) :627.
  • 8王丽,宋兰英,刘运江.乳腺癌组织uPA和PAI-1表达与临床病理因素相关性的探讨[J].中华肿瘤防治杂志,2009,16(22):1765-1769. 被引量:7
  • 9陈旭伟,孙伟,崔世义.uPA、PAI-1的表达和MVD计数与浸润性乳腺癌侵袭性的关系[J].现代生物医学进展,2011,11(12):2307-2309. 被引量:3
  • 10张晶,王春妮,戚美,王妍,刘龙,韩博.二烯丙三硫对乳腺癌MDA-MB-231细胞增殖和侵袭的抑制及对uPA系统的调节[J].山东大学学报(医学版),2012,50(10):61-67. 被引量:3

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部